Plant ID: NPO2154
Plant Latin Name: Ligusticum tenuissimum
Taxonomy Genus: Ligusticum
Taxonomy Family: Apiaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
South Korea
FFAR1; FFAR4; | |
ACHE; | |
CA2; CA12; CA1; CA9; CA14; CA7; CA5A; CA6; | |
PPARA; PPARD; PPARG; | |
HPGD; ALOX15; | |
NFKB1; | |
LMNA; FABP3; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 2 | CYP2A6 | Cytochrome P450 2A6 | P11509 | CHEMBL5282 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Enzyme_unclassified | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Nuclear hormone receptor subfamily 1 group C | PPARG | Peroxisome proliferator-activated receptor gamma | P37231 | CHEMBL235 |
Small molecule receptor (family A GPCR) | FFAR1 | Free fatty acid receptor 1 | O14842 | CHEMBL4422 |
Small molecule receptor (family A GPCR) | FFAR4 | G-protein coupled receptor 120 | Q5NUL3 | CHEMBL5339 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 1.148E-08 | 1.231E-05 | CA1, CA12, CA2, CA5A, CA6, CA7, CA9, PPARA, PPARD, PPARG |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 2.942E-08 | 2.563E-05 | CYP2C19, CYP2C9, CYP2D6 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 6.917E-08 | 4.858E-05 | CYP2A6, CYP2C19, CYP2C9, CYP2D6 |
BP | GO:0050896; response to stimulus | GO:0050728; negative regulation of inflammatory response | 2.117E-07 | 1.317E-04 | FFAR4, NFKB1, PPARA, PPARD, PPARG |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 3.222E-07 | 1.896E-04 | CYP2A6, CYP2C19, CYP2C9 |
BP | GO:0050896; response to stimulus | GO:0009725; response to hormone | 5.541E-07 | 3.175E-04 | CA2, CA9, FABP3, FFAR4, HPGD, NFKB1, PPARA, PPARG |
MF | GO:0003824; catalytic activity | GO:0008392; arachidonic acid epoxygenase activity | 9.919E-07 | 5.143E-04 | CYP2A6, CYP2C19, CYP2C9 |
BP | GO:0051179; localization | GO:0015908; fatty acid transport | 1.114E-06 | 5.390E-04 | FABP3, PPARA, PPARD, PPARG |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 1.092E-06 | 5.390E-04 | ALOX15, CYP2A6, CYP2C19, CYP2C9, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 1.934E-06 | 8.960E-04 | CYP2A6, CYP2C19, CYP2C9 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 4.066E-06 | 1.844E-03 | CA2, CA7 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 9.152E-06 | 3.436E-03 | CYP2A6, CYP2C19, CYP2C9, CYP2D6, PPARD |
BP | GO:0051179; localization | GO:0010891; negative regulation of sequestering of triglyceride | 1.353E-05 | 4.677E-03 | PPARA, PPARG |
MF | GO:0005488; binding | GO:0020037; heme binding | 1.477E-05 | 5.027E-03 | CYP2A6, CYP2C19, CYP2C9, CYP2D6 |
BP | GO:0051179; localization | GO:0010887; negative regulation of cholesterol storage | 2.028E-05 | 5.969E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0010871; negative regulation of receptor biosynthetic process | 2.028E-05 | 5.969E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:2001300; lipoxin metabolic process | 2.028E-05 | 5.969E-03 | ALOX15, HPGD |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 2.025E-05 | 5.969E-03 | CYP2C19, CYP2C9, CYP2D6 |
MF | GO:0005488; binding | GO:0050543; icosatetraenoic acid binding | 2.028E-05 | 5.969E-03 | FABP3, PPARG |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 2.028E-05 | 5.969E-03 | CA1, CA2 |
MF | GO:0140110; transcription regulator activity | GO:0004879; nuclear receptor activity | 2.622E-05 | 7.318E-03 | PPARA, PPARD, PPARG |
BP | GO:0008152; metabolic process | GO:0009804; coumarin metabolic process | 2.838E-05 | 7.724E-03 | CYP2A6, CYP2D6 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 6.542E-21 | 1.425E-16 | CA1, CA12, CA14, CA2, CA5A, CA6, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.766E-16 | 1.923E-12 | CA1, CA12, CA14, CA2, CA5A, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.008E-14 | 4.389E-11 | CA1, CA12, CA2, CA5A, CA6, CA7, CA9 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 1.869E-20 | 1.495E-18 | CA12, CA1, CA2, CA5A, CA7, CA6, CA9, CA14 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.093E-06 | 2.915E-05 | CYP2C9, CYP2A6, CYP2D6, CYP2C19 |
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 1.093E-06 | 2.915E-05 | FABP3, PPARG, PPARA, PPARD |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 7.601E-06 | 1.216E-04 | CYP2C9, CYP2D6, ALOX15, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 4.760E-06 | 9.521E-05 | CYP2C9, ALOX15, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 4.807E-05 | 6.409E-04 | CYP2C9, ALOX15, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 7.840E-05 | 8.960E-04 | CYP2C9, CYP2A6, CYP2D6 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.109E-04 | 1.109E-03 | CYP2C9, CYP2A6, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05202 | Transcriptional misregulation in cancer | 1.112E-03 | 9.885E-03 | HPGD, PPARG, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 1.943E-03 | 1.554E-02 | NFKB1, PPARD |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | FFAR1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | FFAR1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Non-insulin dependent diabetes | E11.9 | FFAR1; |